The MedAccred Plastics Task Group has released its first set of audit criteria. AC8160 MedAccred Audit Criteria for Injection Molding will be used during MedAccred audits conducted at companies manufacturing resin based components via various processes including injection molding, insert molding, overmolding, injection blow molding, transfer molding and compression molding. The audit will robustly assess a company’s ability to consistently manufacture components that conform to the applicable technical specifications and customer requirements.
The new audit criteria were developed by the MedAccred Plastics Task Group which is comprised of technical experts from Johnson & Johnson, Philips, Stryker Corporation, Baxter Healthcare, Becton, Dickinson & Co., Boston Scientific, Medtronic, Mack Molding, BMP Medical and MTD Micro Molding.
PRI’s Executive Vice President and Chief Operating Officer, Joseph Pinto, noted the importance of the new audit criteria for the MedAccred program, commenting “I would like to thank the industry participants who have worked so hard on developing the MedAccred injection molding audit criteria. The field of plastics manufacturing is extensive and involves a significant number of device manufacturers and their respective supply chains. Accreditation to AC8160 will enable companies to demonstrate their commitment to quality and their process expertise to their existing and prospective customers.”
Companies interested in gaining accreditation for Plastics Injection Molding are encouraged to contact Justin McCabe, PRI’s Plastics Staff Engineer (email@example.com) for more information. Companies achieving accreditation will be listed on MedAccred’s Qualified Manufacturers List (located at www.eAuditNet.com).